Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CDMO
631 Articles Available
1
27
Can't find what you're looking for? Try our
advanced search
.
CDMO Service and Capacity Expansion
Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing
PR-M05-23-01
RNA Manufacturing
Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.
PR-M04-23-01
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
PAO-04-23-CL-01
Microbiome Therapeutic Innovation
Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future
PAO-03-23-CL-08
Consulting
Supporting Drug Development – Increasing Probability of Success
PAO-03-23-CL-04
CDMO Leadership Award
Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards
PR-M03-23-04
New R&D Center
Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy
PAO-02-23-CL-07
mRNA Ultra-Cold Chain Management
Ultra-Cold Chain and Supply Chain Management Strategies for mRNA
PAO-02-23-CL-09
UN Global Compact
CDMO Joins United Nations Global Compact
PR-M03-23-02
CDMO Leadership Award
Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise
PR-M03-23-01
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
PAO-02-23-CL-06
New CDMO Facility
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
PAO-02-23-PATV-04
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
PAO-01-23-CL-04
Controlled Substances in Clinical Trials
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
PAO-01-23-CL-03
Quality by Design
A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies
PAO-11-022-CL-06
Custom Lipid Nanoparticle Development
The Value of a Custom Lipid Solutions Provider for mRNA Delivery
PAO-11-022-CL-17
Biomanufacturing
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
PR-M12-22-02
PLIs
A Strategic Approach to Pre-License Inspections
PAO-11-022-CL-03
Microbiome-Based CDMO
Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing
PAO-11-022-CL-13
CDMO
Goodwin Biotechnology Inc. is Now GBI, as Part of their Rebranding Initiative on Their 30-Year Anniversary!
PR-M12-22-02
Biomanufacturing
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
PAO-11-022-CL-11
New cGMP Facility
Alcami Builds cGMP Biostorage Facility in North Carolina
PR-M12-22-01
Cell Line Development Technology
Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering
PR-M11-22-09
Olon, International API Supplier, Releases New 2022 Sustainability Report
PR-M11-22-08
1
27
»